Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

Sentinel Node Biopsy Gains Ground in Endometrial Cancer

Sentinel-based lymph node procedures for endometrial cancer staging rise, while systematic lymphadenectomy rates fall by nearly half between 2018 and 2022.

Vulvar Surgery Boosts Sexual Function in Lichen Sclerosus

Surgical correction of vulvar scarring in patients with lichen sclerosus reduced sexual distress and improved function, with most reporting significant pain relief and enhanced clitoral sensation.

Can Endoscopic Mastectomy Reduce Visible Scarring?

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

GSK, Hansoh's Bone Cancer Drug Meets Main Goal in Late-stage Trial

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Liberalized Diet Fails to Match Neutropenic Safety

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

Chordoma Guidance Moves Into Age of Shared Decision-Making

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

Sentinel-based lymph node procedures for endometrial cancer staging rise, while systematic lymphadenectomy rates fall by nearly half between 2018 and 2022.

Surgical correction of vulvar scarring in patients with lichen sclerosus reduced sexual distress and improved function, with most reporting significant pain relief and enhanced clitoral sensation.

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

News All Time

Q&A: Can More Patients With MIBC Keep Their Bladder?

Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.

Do HIV, Organ Transplant Raise Odds of HPV-Related Cancers?

A study evaluates whether people with HIV infection and solid organ transplant recipients have higher odds of HPV-related cancers than unexposed control individuals.

Man Diagnosed With Ehrlichiosis After Heart Transplant

A heart transplant recipient developed fever, confusion, and worsening cytopenias before an unexpected tick-borne infection was identified and treated successfully.

Aesthetic Medicine

Aesthetic Medicine : The Aesthetic Medicine News & Perspectives presents the latest information on anti-aging treatments, injectable and implantable soft tissue fillers, botulinum toxin treatments, laser surgery, and other treatments to repair and improve the function and cosmetic appearance of skin tissue.

PET-CT Linked to Improved Margin Assessment in Breast Cancer

Researchers compare success rates for addressing positive margins without intraoperative margin assessment with specimen PET-CT in patients with invasive ductal carcinoma.

Water Ablation Shows Early Promise for Prostate Cancer

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural complications.

Vacuum-Tech May Improve Outcomes of Kidney Stone Surgery

Vacuum-assisted flexible ureteroscopy may help clear large kidney stones as well as or better than mainstay treatments, with favorable outcomes after surgery.

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

Recommended News For You

Australian researchers attribute drop in melanoma rates to increasingly diverse population

The Cherenkov color image shows the possibility of improving the quality of radiation therapy.

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Recommended Articles For You

All You Need To Know About Partial Thromboplastin Time (PTT) Test 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Case Study: Artificial Intelligence in Early Cancer Detection 

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do I qualify for a cancer clinical trial?

2.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

3.

New Zealand and Australian breast cancer rates among the highest in the world, global study finds

4.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

5.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

1.

Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025

2.

Progressive Perspectives in Oncology Across Clinical Settings

3.

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery

4.

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma

5.

Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

3.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot